Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind Placebo-controlled Clinical Study to Assess Safety, Tolerance, Pharmacokinetics, Pharmacodynamic of Multiple-dose Kukoamine B Mesilate in Sepsis Patients

NCT03237728 is registered in ClinicalTrials.gov with Tianjin Chasesun Pharmaceutical Co., LTD as lead sponsor.

NCT NCT03237728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03237728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind Placebo-controlled Clinical Study to Assess Safety, Tolerance, Pharmacokinetics, Pharmacodynamic of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
Lead sponsor
Tianjin Chasesun Pharmaceutical Co., LTD
Phase
Phase 1
Overall status
Completed
Start date
July 28, 2017
Completion date
September 25, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis